Overview

Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock.

Status:
Terminated
Trial end date:
2019-11-05
Target enrollment:
0
Participant gender:
All
Summary
The main objectives of the study are 1)to examine the immediate (2 hours) and delayed (8 hours) effects of intravenous hydrocortison on macro and microvascular post-ischemic vasoreactivity, in septic shock adult patients; 2) to examine possible correlations between post-ischemic flow-mediated dilation (FMD) of the brachial artery (assessed by ultrasound imaging) and post-ischemic recovery slope of the thenar oxygen saturation (StO2) (assessed by near-infrared spectroscopy).
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Centre Hospitalier Régional d'Orléans
Treatments:
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate
Criteria
Inclusion Criteria:

- age over 18 yrs

- consent obtained

- septic shock (according to international definition)

- patient sedated and submitted to invasive mechanical ventilation

- no need for surgery expected within 24 hours after enrollment

- patient has received at least one dose of large spectrum antibiotics

- superior vena cava catheter in place

- patient carrying a thermodilution device for cardiac output measurement

- stable mean arterial pressure within 65-5 mmHg limits for at least 2 hours;

Exclusion Criteria:

- pregnancy

- age below 18 years

- patient treated with iv continuous epinephrine

- chronic occlusive arteriopathy of the upper limbs

- regular or recent treatment with glibenclamide or glipizide

- regular or recent treatment with steroids

- known surrenal insufficiency